companydata.dkcompanydata.dk

Evaxion A/S: Financial statements 2018

CVR: 31762863

Source: annual report 2018, Danish Business Authority

01/01/2018 – 31/12/2018

Evaxion A/S (CVR 31762863) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -8,390,221 and a net result of DKK -17,060,437 compared with DKK -10,370,605 the year before. Equity in the 2018 report amounted to DKK 38,414,458. The solvency ratio was 71%. The company had 18 employees in the financial year.

Gross Profit
DKK -8,390,221
Profit/Loss
DKK -17,060,437
Equity
DKK 38,414,458
Total Assets
DKK 54,114,893
Employees
18

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018--8.4 mio.-17.1 mio.38.4 mio.18
2017--4.5 mio.-10.4 mio.15.8 mio.13
2016--524 t.-5 mio.10 mio.14
2015--5.1 mio.-6 mio.13 mio.-
2014--399 t.-1.5 mio.9.9 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

Evaxion A/S: The 2017 annual report is outJun 9, 2018

Evaxion A/S has published its annual report for 2017. Gross profit came to DKK -4,454,031, and the net result was DKK -10,370,605.

Steven J. Projan joins the board of Evaxion A/SJun 1, 2018

As of June 1, 2018, Steven J. Projan has joined the board of directors of Evaxion A/S.

Roberto Prego Pineda joins the board of Evaxion A/SJun 1, 2018

As of June 1, 2018, Roberto Prego Pineda has joined the board of directors of Evaxion A/S.

Roberto Prego Novo leaves the board of Evaxion A/SJun 1, 2018

As of June 1, 2018, Roberto Prego Novo has left the board of directors of Evaxion A/S.

About Evaxion A/S

Evaxion A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named EVAXION BIOTECH A/S and EVAXION BIOTECH ApS. The management consists of Helen Katrina Tayton-Martin, Andreas Holm Mattsson and Thomas Frederik Schmidt. The board consists of Marianne Søgaard (chair), Jens Bitsch-Nørhave, Lars Holtug and Lars Aage Staal Wegner. The company is owned by BNY (Nominees) Limited (as nominee of The Bank of New York Mellon). The company has 24 employees (2018). In 2025, the company reported revenue of DKK 48,112,000 and a net result of DKK -51,489,000 compared with DKK -73,277,000 the year before. Equity in the 2025 report amounted to DKK 108,250,000.

Source: annual report 2025, Danish Business Authority